November 12, 2025 · Form 4 insider transaction
Valantine Hannah bought 25,484 shares of BridgeBio Pharma, Inc. at $48.45 per share, a transaction worth $1.23M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.